Edwards Lifesciences Corp

NYSE:EW 4:00:00 PM EDT

78.21

0.00 (0.00%)

6:49:04 PM EDT: $78.50 +0.29 (+0.37%)

Market Cap (Intraday)	45.88B
Current PE	31.98
Forward PE	31.66
2yr Forward PE	28.34

See more stats

Estimates Current Quarter

Revenue	$1.49 Billion
Adjusted EPS	$0.62

See more estimates

10-Day MA	$76.60
50-Day MA	$75.64
200-Day MA	$71.67

See more pivots

Edwards Lifesciences Corp Stock, NYSE:EW

1 Edwards Way, Irvine, California 92614

United States of America

Phone: +1.949.250.2500

Number of Employees: 15800

http://www.edwards.com

Description

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.